AXS-12 is an investigational highly selective potent norepinephrine reuptake inhibitor and cortical dopamine modulator.
GlobalData on MSN2d
Axsome Therapeutics eyes approval after Phase III narcolepsy winAxsome Therapeutics has announced that its investigational narcolepsy therapy has met the primary endpoint in a Phase III ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback